These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2782267)

  • 1. A symposium: Cardiovascular therapy--the next step. Southampton, Bermuda. Proceedings.
    Am J Cardiol; 1989 Sep; 64(11):1F-69F. PubMed ID: 2782267
    [No Abstract]   [Full Text] [Related]  

  • 2. [Value of verapamil in long-term treatment of coronary disease, hypertension and functional disorders of the cardiovascular system].
    Tkaczewski W; Goch JH
    Wiad Lek; 1979 Oct; 32(19):1359-62. PubMed ID: 506277
    [No Abstract]   [Full Text] [Related]  

  • 3. The place of beta-blockers in cardiovascular medicine.
    Cruickshank JM
    Cardiologia; 1995 Nov; 40(11):829-43. PubMed ID: 8706060
    [No Abstract]   [Full Text] [Related]  

  • 4. [Advantages and disadvantages of drug combinations in cardiovascular therapy].
    Schelling JL
    Ther Umsch; 1987 Aug; 44(8):596-600. PubMed ID: 2890217
    [No Abstract]   [Full Text] [Related]  

  • 5. Uses of propranolol in diagnosis and therapy of circulatory diseases.
    Wasyluk J
    Mater Med Pol; 1974; 6(4):325-8. PubMed ID: 4453159
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of calcium antagonists in the treatment of cardiovascular diseases].
    Akhmedkhanov SSh; Pomerantsev VP; Vasiuk IuA; Mdinaradze IuS
    Sov Med; 1985; (3):44-51. PubMed ID: 3895459
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of vasoactive substances in the treatment of cardiovascular diseases].
    Heine H; Schmidt H; Faulhaber HD; Anders G
    Dtsch Gesundheitsw; 1972 Nov; 27(44):2090-3. PubMed ID: 4405750
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vasodilator therapy in cardiology].
    Cárdenas Loaeza M
    Cardiology; 1980; 66 Suppl 2():1-6. PubMed ID: 6116540
    [No Abstract]   [Full Text] [Related]  

  • 9. [The beta-blockers. Introduction].
    Castaigne A
    Rev Prat; 1984 Apr; 34(19):903-4. PubMed ID: 6144158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta receptor antagonists--pharmacologic characteristics and mechanism of action in cardiovascular diseases].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1984; 78(7):255-61. PubMed ID: 6145258
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium antagonists: mechanisms of action and relevance to therapeutics.
    Vaidya AB; Bhatt AD
    J Assoc Physicians India; 1984 Sep; 32(9):815-8. PubMed ID: 6511773
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical use of calcium antagonists].
    Jounela A
    Duodecim; 1986; 102(22):1717-24. PubMed ID: 3803260
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1985; 79(20):867-73. PubMed ID: 3936287
    [No Abstract]   [Full Text] [Related]  

  • 14. The ballistocardiographic effects of orciprenalin in patients with diverse cardiovascular diseases.
    Falcão de Freitas A
    Bibl Cardiol; 1969; 26():12-23. PubMed ID: 5402338
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cardio-vascular pathology].
    Cah Coll Med Hop Paris; 1969 Dec; 10(17):1367-84. PubMed ID: 5379869
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings of the joint WHO/ISH Symposium on Hypertension and Cardiovascular Disease. Melbourne, Australia, December 4th to 7th, 1988.
    Clin Exp Hypertens A; 1989; 11(5-6):753-1216. PubMed ID: 2791326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Calcium channel blockers. Review and attempt at classification].
    van Zwieten PA; Timmermans PB
    Rev Esp Cardiol; 1984; 37(5):322-9. PubMed ID: 6387828
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving concepts in the medical management of hypertension and ischemic heart disease. Proceedings of an international symposium. Paris, France, March 21-22, 1986.
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S1-135. PubMed ID: 2481156
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
    Krasnikova TL
    Klin Med (Mosk); 1996; 74(3):17-21. PubMed ID: 8926692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.